{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T21:28:57Z","timestamp":1778275737070,"version":"3.51.4"},"reference-count":32,"publisher":"American Physiological Society","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American Journal of Physiology-Renal Physiology"],"published-print":{"date-parts":[[2004,10]]},"abstract":"<jats:p>Dysregulation of kidney nitric oxide synthase (NOS) I may alter renal hemodynamics in diabetes. Four types of studies were performed in anesthetized 1- to 2-wk-streptozotocin diabetic rats. 1) Glomerular filtration rate (GFR) was measured before and during NOS I blockade. Subsequent addition of nonspecific NOS blocker tested for residual NO from other isoforms. Acute systemic NOS I blockade reduced GFR only in diabetics. Nonspecific NOS blockade had no additional effect on NOS I-blocked diabetics. 2) Renal blood flow (RBF) was monitored for evidence that tubuloglomerular feedback (TGF) resets during 1 h of continuous activation with benzolamide. NOS I blockade was added to test for the role of NOS I in TGF resetting. During 1 h of TGF activation in controls, RBF initially declined and then returned to baseline. In diabetic and NOS I-blocked rats, RBF declined and remained low. 3) The ability of NOS I blockade to increase the homeostatic efficiency of TGF in diabetes was tested by micropuncture in free-flowing nephrons. The addition of NOS I blocker to the tubular fluid increased TGF efficiency in control and diabetic rats. 4) The influence of distal salt delivery on local NOS I activity was tested by micropuncture. Henle's loop was perfused at varying rates with NOS I blocker while single-nephron GFR (SNGFR) from the late proximal tubule was measured. In controls, NOS I blockade mainly reduced SNGFR when flow through Henle's loop was high. In diabetics, NOS I blockade reduced SNGFR independently of flow through Henle's loop. In conclusion, normally, salt delivered to the macula densa (MD) exerts immediate control over MD NOS I activity. In diabetes, there is ongoing overactivity of NOS I that is not regulated by MD salt.<\/jats:p>","DOI":"10.1152\/ajprenal.00340.2003","type":"journal-article","created":{"date-parts":[[2004,6,23]],"date-time":"2004-06-23T00:54:42Z","timestamp":1087952082000},"page":"F732-F738","source":"Crossref","is-referenced-by-count":52,"title":["Early diabetes as a model for testing the regulation of juxtaglomerular NOS I"],"prefix":"10.1152","volume":"287","author":[{"given":"Scott C.","family":"Thomson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aihua","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norikuni","family":"Komine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John S.","family":"Hammes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roland C.","family":"Blantz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francis B.","family":"Gabbai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"24","reference":[{"key":"R1","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1993.183"},{"key":"R2","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.1995.269.1.F134"},{"key":"R3","unstructured":"Blantz RCand Tucker BJ.Measurements of glomerular dynamics. In:Methods in Pharmacology, edited by Martinez-Maldonado M. New York: Plenum, 1978, p. 141\u2013163."},{"key":"R4","unstructured":"Choi KC, Kim NH, An MR, Kang DG, Kim SW, and Lee J.Alterations of intrarenal renin-angiotensin and nitric oxide systems in streptozotocin-induced diabetic rats.Kidney Int Suppl60: S23\u2013S27, 1997."},{"key":"R5","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2002.00682.x"},{"key":"R6","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2000.00220.x"},{"key":"R7","doi-asserted-by":"publisher","DOI":"10.2337\/diab.43.10.1190"},{"key":"R8","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.2000.279.3.F573"},{"key":"R9","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000033275.17169.67"},{"key":"R10","doi-asserted-by":"publisher","DOI":"10.1159\/000189293"},{"key":"R11","doi-asserted-by":"crossref","unstructured":"Ohishi Kand Carmines PK.Superoxide dismutase restores the influence of nitric oxide on renal arteriolesin diabetes mellitus.J Am Soc Nephrol5: 1559\u20131566, 1995.","DOI":"10.1681\/ASN.V581559"},{"key":"R12","doi-asserted-by":"publisher","DOI":"10.1172\/JCI119394"},{"key":"R13","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.0075.2001"},{"key":"R14","unstructured":"Parving HH, Osterby R, and Ritz E.Diabetic nephropathy. In:The Kidney, edited by Brenner BM. Philadelphia, PA: Saunders, 2000, p. 1731\u20131773."},{"key":"R15","doi-asserted-by":"publisher","DOI":"10.1152\/ajpregu.1999.277.3.R725"},{"key":"R16","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.1991.260.6.F946"},{"key":"R17","doi-asserted-by":"publisher","DOI":"10.1007\/BF00584628"},{"key":"R18","doi-asserted-by":"publisher","DOI":"10.1067\/mlc.2001.112691"},{"key":"R19","doi-asserted-by":"publisher","DOI":"10.1152\/ajpregu.00610.2001"},{"key":"R20","doi-asserted-by":"publisher","DOI":"10.1172\/JCI5156"},{"key":"R21","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.1993.264.6.F930"},{"key":"R22","unstructured":"Thomson SCand Blantz RC.The kidney and nitric oxide. In:The Textbook of Nephrology(4th ed.), edited by Massry J and Glassock R. New York: Williams and Wilkins, 2001, p. 188\u2013192."},{"key":"R23","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.1996.270.3.F461"},{"key":"R24","doi-asserted-by":"publisher","DOI":"10.1172\/JCI10963"},{"key":"R25","doi-asserted-by":"publisher","DOI":"10.1152\/ajpregu.1997.273.4.R1414"},{"key":"R26","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.1998.06713.x"},{"key":"R27","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1996.62"},{"key":"R28","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.1993.265.6.F886"},{"key":"R29","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.1995.269.6.F876"},{"key":"R30","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.1995.269.6.F892"},{"key":"R31","doi-asserted-by":"crossref","unstructured":"Veelken R, Hilgers KF, Hartner A, Haas A, Bohmer KP, and Sterzel RB.Nitric oxide synthase isoforms and glomerular hyperfiltration in early diabetic nephropathy.J Am Soc Nephrol11: 71\u201379, 2000.","DOI":"10.1681\/ASN.V11171"},{"key":"R32","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.89.24.11993"}],"container-title":["American Journal of Physiology-Renal Physiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.physiology.org\/doi\/pdf\/10.1152\/ajprenal.00340.2003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,23]],"date-time":"2021-06-23T17:26:54Z","timestamp":1624469214000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.physiology.org\/doi\/10.1152\/ajprenal.00340.2003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,10]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,10]]}},"alternative-id":["10.1152\/ajprenal.00340.2003"],"URL":"https:\/\/doi.org\/10.1152\/ajprenal.00340.2003","relation":{},"ISSN":["1931-857X","1522-1466"],"issn-type":[{"value":"1931-857X","type":"print"},{"value":"1522-1466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,10]]}}}